PA8.F rises 57% to €0.11 on XETRA 26 Feb 2026: monitor model €0.37 target

The PA8.F stock climbed 57.14% to €0.11 on XETRA on 26 Feb 2026, making it one of Germany’s top gainers today. Trading volume was 1,222 shares versus an average of 2,162, showing selective interest. The move follows no public earnings release today but tracks persistent speculation in the healthcare small-cap segment. We examine what drove the spike, the company’s metrics, technical signals, and model-based targets to help investors interpret this short-term rally.

PA8.F stock: intraday price and volume snapshot

PA8.F stock closed at €0.11, up €0.04 or 57.14%, with a day high and low of €0.11. Market cap stands at €784,707 with 7,133,700 shares outstanding. The 50-day average price is €0.02 and the 200-day average price is €0.01, underlining recent momentum versus historical lows. Relative volume was 0.57, indicating lighter participation compared with the recent average.

PA8.F stock: drivers and news context

There was no confirmed earnings release linked to the jump; the next earnings announcement is scheduled for 02 Apr 2026. Market chatter points to renewed investor interest in Paion AG’s anesthesia and critical care pipeline and small-block buying in XETRA’s healthcare cohort. Sector performance for Healthcare was modest today, up 0.88%, so PA8.F’s move outpaced peers and likely reflects idiosyncratic speculation or position building rather than broad sector flow. For company announcements see Paion’s investor news source.

PA8.F stock: fundamentals and valuation metrics

Paion AG operates in Drug Manufacturers – Specialty & Generic with a reported price-to-sales ratio of 0.02 and a TTM price/earnings of -0.86. Revenue per share TTM is 4.66 and net income per share TTM is -0.08. Gross profit margin is 94.10% while net profit margin is -1.74%, reflecting narrow operating scale and occasional losses. These ratios show a micro-cap with thin liquidity and metrics that can swing widely with small cash flows.

PA8.F stock: technical indicators and momentum

Technicals show mixed momentum: RSI is 44.21, ADX is 43.46 indicating a strong trend, and MACD histogram is slightly negative. Bollinger Bands range €0.05–€0.20, and ATR is €0.03, highlighting high percentage volatility at low nominal prices. On balance, short-term oscillators are oversold to neutral, so the current jump may face resistance near the upper band while trend strength supports follow-through if volume rises.

PA8.F stock: Meyka AI grade and forecast

Meyka AI rates PA8.F with a score of 63.06 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly target of €0.16, a quarterly target of €0.37, and a yearly target of €1.29. Compared with the current €0.11, those imply upside of 45.45%, 236.36%, and 1,068.25% respectively. Forecasts are model-based projections and not guarantees.

PA8.F stock: risks, liquidity and analyst considerations

Key risks include extremely low liquidity, small market cap, and limited public financial disclosure. Average volume is only 2,162 shares, creating execution risk and price gaps on larger orders. Interest coverage is 0.54, and free cash flow metrics are negligible, increasing sensitivity to financing events. Analysts should treat any short-term rallies as speculative until clearer operational catalysts or confirmed partnerships emerge. For market structure context see Deutsche Börse XETRA source.

Final Thoughts

PA8.F stock’s 57.14% jump to €0.11 on 26 Feb 2026 is notable but comes with typical small-cap caveats: low liquidity, wide spreads, and volatile ratios. Our review finds solid short-term momentum (ADX 43.46) but neutral RSI (44.21) and limited volume participation. Meyka AI’s model projects a quarterly target of €0.37 and a yearly target of €1.29, implying substantial model-based upside of 236.36% and 1,068.25% from today’s close. We rate the move as event-driven and speculative; investors should size positions conservatively, monitor the scheduled 02 Apr 2026 earnings announcement, and watch for confirming volume above the 50-day average. Meyka AI provides this as an AI-powered market analysis platform and these projections are model-based, not guarantees or financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.